Advertisement

Reactions Weekly

, Volume 1739, Issue 1, pp 66–66 | Cite as

Bevacizumab/doxorubicin liposomal

Small bowel perforation: case report
Case report
  • 7 Downloads

Reference

  1. Ota T, et al. Doxorubicin hydrochloride and bevacizumab for the patients with platinum-taxane resistant ovarian cancer. European Journal of Gynaecological Oncology 39: 889-893, No. 6, Jan 2018. Available from: URL: http://doi.org/10.12892/ejgo4066.2018 - JapanGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations